Table 1. Demographic and clinical characteristics of patients.
| Group 1 | Group 2 | Group 3 | Group 4 | ||||||||||||||||||
| n | % | Mean±SD | Median | Min-Max | n | % | Mean±SD | Median | Min-Max | n | % | Mean±SD | Median | Min-Max | n | % | Mean±SD | Median | Min-Max | p | |
| Age (year) | 54.9±10.2 | 58.8±9.3 | 60.6±8.7 | 61.8±8.0 | 0,367 | ||||||||||||||||
| Body mass index (kg/m2) | 28.8±5.0 | 29.2±4.4 | 30.7±6.3 | 28.7±3.2 | 0,388 | ||||||||||||||||
| Gender | 0,163 | ||||||||||||||||||||
| Male | 8 | 25,8 | 6 | 19,8 | 11 | 35,5 | 6 | 19,4 | |||||||||||||
| Female | 3 | 33,3 | 4 | 44,4 | 0 | 0 | 2 | 22,2 | |||||||||||||
| Hypertension | 8 | 72,7 | 7 | 70 | 7 | 63,6 | 6 | 75 | 1,000 | ||||||||||||
| Duration of diabetes (year) | 0 | 8.9±3.4 | 8±8.1 | 15±6.1 | 0,162 | ||||||||||||||||
| Oral anti-diabetic use | 0 | 0 | 8 | 80 | 8 | 72 | 3 | 37 | <0.001* | ||||||||||||
| Insulin use | 0 | 0 | 0 | 0 | 1 | 9,1 | 6 | 75 | <0.001* | ||||||||||||
| Hyperlipidemia | 5 | 45 | 4 | 40 | 4 | 36 | 5 | 62 | 0,777 | ||||||||||||
| Ejection fraction | 60 | 50-60 | 60 | 38-65 | 60 | 45-65 | 55 | 40-65 | 0,582 | ||||||||||||
| SD: Standard deviation; Min: Minimum; Max: Maximum; Kruskal-Wallis test was conducted for continuous variables and chi-square test for the categorical variables to assess the differences among four groups * p<0.05. | |||||||||||||||||||||